212 
Sigma Pharmaceuticals, the subject of a A$707 million ($594 million) takeover offer from Africa based Aspen Pharmacare Holdings, fell to the lowest in six weeks in ASX trading on speculation the deal won’t succeed. Sigma is Australia’s biggest drugs distributor and slumped as much as 6.2 percent to 38cents, the lowest since May 21, the day before Aspen’s A$0.60-a-share offer was announced. No statements from either comapny have yet been made.
Terms & Rules
As per ASIC Regulatory Guide 162: All investment tips and comments appearing on this website (Poll results, BLOGS & discussion forums) are submitted by the general public who are not licensed financial advisors. None of the information on this website is financial or investment advice, you should seek independent financial or investment advice by a licensed financial or investment advisor before entering into any position of financial risk. Before using this website, you must agree to the BioInvesting.com.au Terms Of Use
Comments